The Globe and Mail reports in its Friday, Nov. 8, edition that RBC Capital analyst Sabahat Khan has trimmed his share target for ATS to $48 from $52. The Globe's David Leeder writes that analysts on average target ATS shares at $51.29. Mr. Khan says in a note: "ATS's FQ2 results were below consensus while FQ3 revenue guidance was also below Street expectations. The transportation (EV) business is in transition (leading to lower revenue/negatively impacting margins); however, we believe the worst of it is largely behind us. Going forward, our focus is on the core business (i.e., life sciences and F&B plus energy), which is relatively stable through the cycle. We view [Wednesday's] share price weakness as a buying opportunity as we would expect a recovery from current levels as the company reverts toward its historical 'staples-like' exposure." The Globe reported on Oct. 30 that Raymond James analyst Michael Glen had reaffirmed his "outperform" recommendation for ATS. The shares were then going for $42.78. The Globe reported on Oct. 9 that Mr. Khan had reaffirmed his "outperform" recommendation for ATS. In the item, Mr. Khan said, "We expect ATS shares to trend higher." The shares could then be had for $40.74.